Hypogonadism is a medical condition characterized by erotic insufficient production of testosterone by the testes. This hormonal deficiency can significantly affect male reproductive health, sexual function, and overall well-being.
There are two primary types of hypogonadism: primary hypogonadism and secondary hypogonadism. Primary hypogonadism occurs when the testes themselves are unable to produce adequate testosterone. This may result from genetic disorders, injury, infection, or certain medical treatments such as chemotherapy.
Secondary hypogonadism, on the other hand, arises from dysfunction in the hypothalamus or pituitary gland, which are responsible for regulating hormone production in the testes.
Symptoms of hypogonadism may include decreased libido, erectile dysfunction, fatigue, reduced muscle mass, increased body fat, depression, and infertility. In younger individuals, delayed puberty may also occur.
Diagnosis involves measuring testosterone levels through blood tests, often combined with additional hormonal evaluations. Imaging studies may also be conducted to assess the pituitary gland or testes.
Treatment typically involves testosterone replacement therapy, which can be administered through injections, patches, gels, or implants. Proper monitoring is necessary to ensure that hormone levels remain within a safe and effective range.
Managing hypogonadism can significantly improve quality of life, sexual health, and reproductive function in affected individuals.